drugset / Trial / NCT05659459
The KIN-FAST Trial (KIN001 For Accelerated Symptoms Termination) in Non Hospitalized Patients Infected With SARS-CoV-2
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Clinical trial on safety and efficacy of KIN001 in non-hospitalized patients with COVID-19.
Timeline
- Start
- 2022-08-25
- Primary completion
- 2023-10-01
- Completion
- 2023-10-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pamapimod | Small molecule | 75 mg | Oral |
| Subject | Pioglitazone | Small molecule | 5 mg | Oral |